Cardinal Systems

Cardinal Systems is a full service CRO with added-value in International Project Management, Regulatory, Methodology, Statistics and Technology.

In line with the Critical Path Initiative (FDA) and the Road Map to 2015 (EMA), Cardinal Systems proposes innovative designs (e.g. adaptive design methods for clinical trials) and robust technology to optimise new drug development for unmet medical needs.

Cardinal Systems offers clinical trial management with high added-value since 1996 to pharmaceutical industries, biotechnologies and governmental and non profit organizations in the development of new therapeutics.

Cardinal Systems has been participating in healthcare improvement through international clinical trials in various indications.

Launched into the international clinical market through proprietary innovative solutions such as IRS (IVRS/IWRS), eCRF, eCTD and Medical Imaging, Cardinal Systems continues to build long-term partnerships with its clients.

Cardinal Systems headquarter is located in Paris, France, with an affiliate in North America (Canada).

Specialised in innovative methodology (such as adaptive designs) and robust technology, Cardinal Systems offers global clinical trial services with high added-value to biotechnologies.

Supported by an international network of experts, we propose a streamlined and regulatory-compliant workflow and provide our client with data monitoring committee organisation and scientific guidance during clinical trials.

Cardinal Systems technology platform is 21CFR Part 11 compliant, with 24/7 online support.

Antoine Périer, CEO of Cardinal Systems, is vice-president of the ‘New therapeutic products  development committee’ (Commission Développement Nouveaux Produits Thérapeutiques) within France Biotech. François Aubin, MD, MSc, physician and biostatistician, is the Medical and Methodology Director at Cardinal Systems since 2008 and is president of the EFSPI and vice-president of the SFdS-Biopharmacy et Santé group. Caroline Morgan, DPhil, methodologist and biostatistician, is the Director of Clinical Operations at Cardinal Systems since 2005 and specialises in the development of clinical development plans and adaptive designs. Caroline is an active member of the PhRMA adaptive design working group. All projects contracted to Cardinal Systems are overseen by at least one of these senior staff members.